Literature DB >> 11344015

Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP).

M Takanashi1, H Mochizuki, K Yokomizo, N Hattori, H Mori, Y Yamamura, Y Mizuno.   

Abstract

Autosomal recessive juvenile parkinsonism (ARJP) is a distinct clinical and genetic entity characterized by highly selective neuronal death in the substantia nigra (SN) and locus coeruleus neurons without Lewy body formation. The mechanism of neuronal death of ARJP is still unknown. Our study demonstrated that iron staining was more intense in ARJP than in both controls and sporadic Parkinson's disease (PD), and there were differences in the pattern of distribution of iron staining between ARJP and PD. In addition neurites of SN in ARJP showed intense iron staining. Thus, we postulate that oxidative stress may play an important role in the neurodegeneration that occurs in ARJP.

Entities:  

Year:  2001        PMID: 11344015     DOI: 10.1016/s1353-8020(00)00050-x

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  18 in total

1.  Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells.

Authors:  Hui Yang; Hai-Yan Zhou; Biao Li; Guo-Zhong Niu; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-20       Impact factor: 4.147

Review 2.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

Review 3.  Ultrastructural aspects of iron storage, transport and metabolism.

Authors:  Theodore C Iancu
Journal:  J Neural Transm (Vienna)       Date:  2011-02-12       Impact factor: 3.575

Review 4.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 5.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 6.  The ongoing pursuit of neuroprotective therapies in Parkinson disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  Nat Rev Neurol       Date:  2014-12-02       Impact factor: 42.937

Review 7.  Iron accumulation in Parkinson's disease.

Authors:  Hideki Mochizuki; Toru Yasuda
Journal:  J Neural Transm (Vienna)       Date:  2012-10-16       Impact factor: 3.575

8.  Genetic neuropathology of Parkinson's disease.

Authors:  Mark R Cookson; John Hardy; Patrick A Lewis
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Dietary iron intake and risk of Parkinson's disease.

Authors:  Giancarlo Logroscino; Xiang Gao; Honglei Chen; Al Wing; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

Review 10.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.